Jesse Crowne has over 26 years of experience as an investor in and operator of rapidly growing healthcare companies and currently teaches finance classes to graduate students at Westminster College, as well as doing charity work with the Leukemia and Lymphoma Society (LLS)— Utah LLS chapter named him Man of the Year in 2017.

Before joining EdJen, Mr. Crowne served as Chief Executive Officer of Nepetx, a pre-clinical biotech company developing an orally administered enzymatic therapy for the treatment of Celiac Disease.

He previously served as Executive Co-Chairman at Medovex Corporation, a publicly-traded medical device company focused on commercializing a minimally invasive, single-use device for the treatment of lower back pain (facet joint syndrome) that provides long-term pain relief. Mr. Crowne has also served as President of Vavotar Life Sciences, a clinical-stage biotech company developing antibody-drug conjugates for oncology applications.

He expanded his operations and investing skillsets during his time as Managing Partner with Gorlin Companies, a healthcare-focused Single-Family Office based out of Aspen, CO. In this capacity, he had the opportunity to co-found several companies and serve on their management teams.

Mr. Crowne began his career as a compounding pharmacy technician before moving over to the world of finance and becoming an Associate with White Pine Medical, a private equity investment vehicle and subsidiary of Essex Woodlands Health Ventures focused on the medical device sector. Within White Pine, he was responsible for tracking and reporting portfolio company performance, completing market research, developing financial models, sourcing deal flow, leading due diligence of potential investments, and presenting financial plans and strategic initiatives to general and limited partners.

Mr. Crowne received an MBA and an MPH from Westminster College and BS degrees in Biology and Economics from the University of Utah.